Pure Global
NCT06335225

Establishment of Precise Nutrition Management Scheme for Patients With Prediabetes Based on Nutrigenomics

China-Japan Friendship Hospital·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Prediabetes
Drug/Device/Intervention
Precise nutritional intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
China-Japan Friendship Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Mar 13, 2024
End date
Jul 31, 2025
Enrollment
60 participants
Primary outcome

HbA1c

Summary

With the aging of population and the change of lifestyle, the prevalence of prediabetes is
 increasing year by year. Nutritional factors are one of the important environmental factors
 in the occurrence and development of abnormal glucose metabolism. The medical nutritional
 treatment of diabetes is recommended as the cornerstone of diabetes treatment by various
 guidelines. With the development of nutrigenomics, it has been found that genes related to
 the absorption, metabolism, distribution and excretion of various nutrients are related to
 diabetes. This study intends to conduct precision nutrition intervention for prediabetic
 patients based on nutritional genes, and evaluate the effectiveness and safety of these
 nutritional interventions.

ICD-10 classifications
Diabetes mellitusDiabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecifiedOther specified diabetes mellitusDiabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependentDiabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06335225
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06335225 through Pure Global AI's free database. This phase not specified trial is sponsored by China-Japan Friendship Hospital and is currently Recruiting. The study focuses on Prediabetes. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.